Alex D'souzaManaging Editoreditor@healthcaretechoutlook.comRegenerative medicine is advancing into clinical use, utilizing materials that release growth factors and cytokines to aid tissue healing, particularly in chronic wounds. This evolving field is merging with cellular therapies, promising to treat various diseases and improve overall health. Regenerative medicine aims to restore damaged tissue and create solutions for permanently damaged organs, potentially curing previously untreatable conditions. Although a relatively new field, diverse research groups are working on translating these approaches from the lab to clinical applications. Academic startups are crucial in advancing regenerative medicine products to benefit patients.The global Regenerative Medicine Market is poised for remarkable growth, with a projected CAGR of 22.8 percent from 2023 to 2032. In 2022, the market size is expected to reach $65.08 bn, and it's anticipated to surge to $174.72 bn by 2032. This growth is primarily driven by the continuous advancement of regenerative technologies, particularly the expanding applications of stem cells in regenerative medicine. The market is expanding due to advanced technologies being introduced by providers to enhance stem cell research and commercial applications.This Healthcare Tech Outlook edition brings the key developments in regenerative medicine through thought leadership articles from Alfredo Morales, MD, MHA, Director of Virtual Care, North Mississippi Health Services, and Sandi Wagner, Virtual Services Director, Saint Francis Health System.Alfredo Morales discusses the healthcare challenges in rural America, emphasizing the importance of virtual care in providing specialty care, mental health services, and opioid addiction treatment. Sandi Wagner explores several key aspects of healthcare, including virtual services, the role of remote patient monitoring (RPM) in patient care, and how telehealth influences patient engagement.This edition also features Regenative Labs, a company that provides high-quality human tissue allografts for structural tissue repair, including a unique umbilical cord-derived allograft for treating structural defects.In this edition featuring the Top Regenerative Medicine Solutions Providers, we hope you find the appropriate company suited to your business requirements.Let us know your thoughts.Future-Proofing Healthcare with Regenerative Medicine EditorialManaging EditorAlex D'souzaEditorial StaffAaron PaulJoe PhillipJames SmithMark Robert Wilson BrunoVega StanleyDavis MillsDebbie WillisVisualizerUTLOOKHealthcare Tech Copyright © 2023 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEmail:sales@healthcaretechoutlook.comeditor@healthcaretechoutlook.commarketing@healthcaretechoutlook.comImmanuelChris LynnNOVEMBER - 20 - 2023, volume 09 - Issue 16 Published by ValleyMedia, Inc. (ISSN 2691 - 3933)To subscribe to HealthcareTech OutlookVisit www.healthcaretechoutlook.com UTLOOKHealthcare Tech
< Page 5 | Page 7 >